Article Text

PDF
05 The cardioprotective effect of mildronate is associated with decreased CPT I-dependent fatty acid metabolism in mitochondria
  1. J Kuka1,
  2. M Makrecka1,2,
  3. R Vilskersts1,2,
  4. M Dambrova1,2
  1. 1Latvian Institute of Organic Synthesis, Laboratory of Pharmaceutical Pharmacology, Latvia
  2. 2Riga Stradins University, Faculty of Pharmacy, Latvia

Abstract

Mildronate is a cardioprotective agent whose mechanism of action is based on decrease in L-carnitine concentration in heart tissue and concomitant decrease in fatty acid metabolism. The present study was undertaken to highlight the role of mitochondrial energy pathways in the anti-infarction mechanism of mildronate. Male Wistar rats received water or mildronate (100 mg/kg, orally) for 14 days. The isolated rat heart ischaemia-reperfusion injury study was performed based on Langerdorff technique. L-carnitine concentration and carnitine palmitoyltransferase I (CPT I) dependent or independent mitochondrial respiration were measured. In addition, the effect of cytochrome c on respiration of saponin-permeabilised cardiac ventricular fibres isolated from ischaemic hearts was determined. Mildronate treatment induced a significant threefold decrease in the L-carnitine concentration in heart tissue and decreased infarct size by 38%. Treatment with mildronate decreased CPT I-dependent mitochondrial respiration on palmitoyl-CoA by 27%, while it had no effect on CPT I-independent respiration on palmitoylcarnitine. Mildronate treatment significantly diminished the ischaemia-induced respiration stimulation by exogenous cytochrome c when pyruvate/malate and succinate were used as respiratory substrates. In conclusion, our results provide evidence that the anti-infarction activity of mildronate is related to decrease in CPT I-dependent fatty acid metabolism. The cardioprotective effect of mildronate could be partially attributed to the maintenance of the integrity of mitochondrial outer membrane.

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.